UK trials teen social media bans ahead of potential crackdown March 25, 2026 Hundreds of teenagers across the UK are set to take part in a government-backed trial of social media restrictions, as ministers weigh whether to introduce a nationwide ban for under-16s. The six-week pilot will see 300 teenagers aged between 13 and 17 split into four groups, testing different levels of access to apps such as [...]
If Reeves wants Britain to lead in AI, she must offer tax incentives March 25, 2026 The government is aware of the levers it’s able to pull to compete on AI: planning, electricity connections, visas, higher education policy, direct subsidies. But where’s tax? Asks Tim Sarson A couple of weeks ago one of those mini news stories came along, the sort that is so neatly zeitgeisty that it demands further consideration. [...]
The manosphere’s dangerous ‘get rick quick’ promise March 25, 2026 Online influencers like those highlighted in Louis Theroux’s Inside the Manosphere documentary are framing trading as an easy route to financial success and masculine dominance. That’s not education, it’s manipulation, says Lewis Crompton The promise of quick wealth has always had a powerful pull. But today it is being repackaged and amplified through social media, [...]
Has YouGov been barraged by Farage? March 25, 2026 Nigel Farage has never been shy in locking horns with big business. Just ask Dame Alison Rose, whose stint at Natwest came to a sharp halt after a row with Farage over a debanking. The British banker resigned after Natwest admitted to “serious failings” in closing the Reform UK leader’s account at its high-net-worth subsidiary [...]
Skechers Athlete Matt Fitzpatrick Wins Third PGA Tour Victory at Valspar Championship March 24, 2026 Competing in Skechers Golf Footwear and Performance Apparel, Fitzpatrick Closed with a Tournament-winning Performance at Innisbrook Resort.
Arm Expands Compute Platform to Silicon Products in Historic Company First March 24, 2026 News Highlights Arm extends its platform breadth to include production silicon products for the first time, offering the broadest choice of compute across IP, Arm Compute Subsystems (CSS) and silicon Introducing the first Arm-designed data center CPU, the Arm AGI CPU, for agentic AI infrastructure, delivering more than 2x performance per rack compared with x86 platforms* Developed with lead partner Meta, with other customers and leading ODMs committed for production, the Arm AGI CPU is backed by strong support from the global ecosystem
eClerx named as a Representative Vendor in the 2025 Gartner® Market Guide for Digital Shelf Analytics March 24, 2026 eClerx Services Ltd (ECLERX.NS), a leading productized services company, today announced that it was named as a Representative Vendor in the Gartner Market Guide for Digital Shelf Analytics. According to Gartner, “we selected vendors for this Market Guide based on their ability to offer insights from the digital shelves of multiple online marketplaces, retailers or [...]
Xsolla and Stevenage FC Launch Charity Campaign With SpecialEffect to Make Gaming Accessible for All March 24, 2026 Donation Of 50 Accessible Setups Reinforces Xsolla’s Commitment To Inclusive Gaming
Trian and General Catalyst Agree to Increase Merger Consideration to $52.00 Per Share in Cash for Janus Henderson Group plc and Have Made the Only Actionable Proposal March 24, 2026 Amended Merger Agreement Represents a $3.00 All-Cash Price Increase; 25% Premium to Unaffected Share Price; Parties Committed to Closing by Mid-2026 Special Committee Determines that Victory Capital’s Revised Unsolicited March 17, 2026 Proposal Is Not Actionable and Is Not in Best Interests of Janus Henderson and Its Shareholders Amended Merger Agreement’s All-Cash Transaction With Trian and General Catalyst Is Superior From an Expected Value and Certainty Perspective and Is the Only Actionable Proposal
Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights March 24, 2026 COMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect in treatment resistant depression (TRD), with a generally well-tolerated and safe profile Across three large trials in TRD, including two positive Phase 3 studies, COMP360’s differentiated profile is redefining rapidity and durability for TRD patients and demonstrating a consistent level of clinical effect that has never been achieved before Compass will meet with the FDA to confirm alignment on a rolling submission and review, and expects to complete the NDA submission in Q4 Compass is rapidly advancing commercial readiness plans and expects COMP360 will fit seamlessly across diverse healthcare settings at launch Phase 2b/3 trial in PTSD initiating, following FDA acceptance of IND application Successful $150 million financing in February and exercise of $200 million in warrants extends cash runway into 2028